|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.711
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.630
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.581
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.521
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.519
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.460
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.340
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.336
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.334
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.323
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.323
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.313
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.290
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.286
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.285
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.279
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.273
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.264
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.258
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.257
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.256
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.240
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.232
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.224
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.217
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.214
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.211
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.211
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.207
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.200
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.200
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.197
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.194
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.193
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.192
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.189
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.184
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.181
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.170
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.167
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.166
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.165
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.160
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.159
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.157
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.156
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.156
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.153
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.152
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.152
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.151
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.149
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.149
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.147
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.145
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.143
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.141
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.139
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.138
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.138
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.136
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.135
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.134
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.133
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.133
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.133
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.131
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.130
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.128
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.128
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.125
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.123
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.123
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.123
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.120
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.120
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.120
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.119
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.118
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.112
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.111
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.111
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.110
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.110
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.109
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.107
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.107
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.106
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.103
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.103
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.102
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.100
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.100
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.099
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.098
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.098
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.098
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.097
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.096
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.096
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.096
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.094
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.094
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.093
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.093
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.092
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.092
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.092
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.091
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.091
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.090
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.089
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.088
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.087
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.087
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.087
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.087
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.086
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.086
|
Mouse |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.086
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.086
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.086
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.085
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.085
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.085
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.085
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.085
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.085
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.084
|
|
|
|
memory
|
GO:0007613 |
58 |
0.084
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.084
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.083
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.082
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.082
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.082
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.082
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.082
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.081
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.081
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.081
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.080
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.079
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.079
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.079
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.078
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.078
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.078
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.078
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.078
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.078
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.078
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.076
|
Mouse |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.076
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.076
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.076
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.075
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.075
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.074
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.074
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.073
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.073
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.073
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.073
|
Mouse |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.073
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.073
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.073
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.073
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.072
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.072
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.072
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.071
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.071
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.071
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.071
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.071
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.070
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.069
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.069
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.069
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.068
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.068
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.068
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.068
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.067
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.067
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.067
|
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.067
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.066
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.066
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.066
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.066
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.066
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.066
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.065
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.065
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.065
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.064
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.064
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.064
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.063
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.063
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.063
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.063
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.063
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.062
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.062
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.061
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.061
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.061
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.061
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.061
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.060
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.060
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.060
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.060
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.060
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.059
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.059
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.059
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.058
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.058
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.058
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.058
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.057
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.057
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.057
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.056
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.056
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.056
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.055
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.055
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.055
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.054
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.054
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.054
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.054
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.054
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.054
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.053
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.053
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.053
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.053
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.053
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.053
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.052
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.052
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.052
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.052
|
|
|
|
parathyroid hormone secretion
|
GO:0035898 |
2 |
0.051
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.051
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.051
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.050
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.050
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.050
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.050
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.050
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.050
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.050
|
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.049
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.049
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.049
|
Mouse |
|
|
epidermis development
|
GO:0008544 |
187 |
0.049
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.048
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.048
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.048
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.048
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.048
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.048
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.047
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.047
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.047
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.047
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.047
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.047
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.046
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.046
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.045
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.045
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.045
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.045
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.045
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.045
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.045
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.045
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.044
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.044
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.044
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.044
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.044
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.044
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.044
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.044
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.044
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.044
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.044
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.043
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.043
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.043
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.043
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.043
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.043
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.043
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.043
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.042
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.042
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.042
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.042
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.041
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.041
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.041
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.041
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.040
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.040
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.040
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.040
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.040
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.040
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.040
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.040
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.040
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.040
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.040
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.039
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.039
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.039
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.039
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.039
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.038
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.038
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.038
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.038
|
|
|
|
learning
|
GO:0007612 |
98 |
0.038
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.038
|
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.038
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.038
|
|
|
|
dendritic spine morphogenesis
|
GO:0060997 |
22 |
0.038
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.038
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.037
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.037
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.037
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.037
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.037
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.037
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.037
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.037
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.037
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.037
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.037
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.037
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.036
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.036
|
Mouse |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.036
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.036
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.036
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.036
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.036
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.036
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.035
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.035
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.035
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.035
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.035
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.035
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.035
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.035
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.035
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.035
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.035
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.035
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.035
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.035
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.035
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.034
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.034
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.034
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.034
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.034
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.033
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.033
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.033
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.033
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.033
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
8 |
0.033
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.033
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.033
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.032
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.032
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.032
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.032
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.032
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.032
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.032
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.032
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
|
|
corpus callosum development
|
GO:0022038 |
10 |
0.031
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.031
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.031
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.031
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.031
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.031
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
10 |
0.031
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.031
|
|
|
|
regulation of long term synaptic depression
|
GO:1900452 |
3 |
0.031
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.031
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.031
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.031
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.030
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.030
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.030
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.030
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.030
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.030
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.030
|
Mouse |
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.030
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.030
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.030
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.030
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.030
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.029
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.029
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.029
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.029
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.029
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.029
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.029
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.028
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.028
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.028
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.028
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.028
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.028
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.028
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.028
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.028
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.027
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.027
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.027
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.027
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.027
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.027
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.027
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.027
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.027
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.027
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.027
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.027
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.027
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.026
|
|
|
|
regulation of glutamate receptor signaling pathway
|
GO:1900449 |
16 |
0.026
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.026
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.026
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.026
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.026
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.026
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.026
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.026
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.026
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.026
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.025
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.025
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.025
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.025
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.025
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.025
|
|
